The HHS Policy Update: The Future of 7-OH Distribution in the U.S. marks a critical turning point in how emerging compounds—particularly 7-hydroxymitragynine—are evaluated and regulated. As interest in kratom-derived alkaloids grows, U.S. regulators are moving to address safety concerns, standardization gaps, and the rapid […]